| 122nd MAINE LEGISLATURE | |||||||||
| LD 1618 | LR 0487(02) | ||||||||
| An Act Regarding Advertising by Drug Manufacturers | |||||||||
| Fiscal Note for Bill as Amended by Committee Amendment " " | |||||||||
| Committee: Health and Human Services | |||||||||
| Fiscal Note Required: Yes | |||||||||
| Majority Report | |||||||||
| Fiscal Note | |||||||||
| Undetermined current biennium revenue increase - Other Special Revenue Funds | |||||||||
| Undetermined current biennium cost increase - Other Special Revenue Funds | |||||||||
| Minor cost increase - General Fund | |||||||||
| Minor revenue increase - General Fund | |||||||||
| Correctional and Judicial Impact Statements | |||||||||
| Establishes new violations of the Maine Unfair Trade Practices Act. | |||||||||
| The collection of additional fines may increase General Fund revenue by minor amounts. | |||||||||
| Fiscal Detail and Notes | |||||||||
| Assumes additional costs to the Department of Human Services to implement the provisions of the bill would be funded with fees on certain manufacturers of prescription drugs. The amount of fees that will be generated cannot be determined at this time. | |||||||||
| Any additional costs to the Department of the Attorney General can be absorbed utilizing existing budgeted resources. | |||||||||